Steven Cohen Inventiva S.A. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$12.55 - $19.0 $520,686 - $788,291	-41,489 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.35 - $14.5 $2.26 Million - $2.88 Million	-198,846 Reduced 82.74%	41,489 $602,000
Q3 2020 Nov 16, 2020	BUY	$9.87 - $13.42 $2.37 Million - $3.23 Million	240,335 New	240,335 $2.84 Million

4.86M

Ticker IVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,134,200
Market Cap $150M
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.